Over the last few years, GLP-1 receptor agonists like semaglutide and tirzepatide have become household names in metabolic health, weight loss, and diabetes care
In particular, mature neurons and progenitor cells in the adult rat hippocampus express GIP receptors, and treatment with GIP is able to promote neuronal cell proliferation [39]
Zhou ZD, Yi L, Popawska-Domaszewicz K, Chaudhuri KR, Jankovic J, Tan EK (2025) Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges
Dietary supplements are not appropriate for everyone and may interact with other supplements or medications, so talk to your healthcare provider before adding one to your routine
The care and communication has been second to none
The global GLP-1 pharmaceutical market alone was valued at $53.46 billion in 2024 and is projected to grow at a CAGR of 17.5% from 2025 to 2030, reaching approximately $156.71 billion by 2030**